These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10901589)

  • 1. Novel therapeutic targets in multiple myeloma.
    Davies FE; Anderson KC
    Eur J Haematol; 2000 Jun; 64(6):359-67. PubMed ID: 10901589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the bone marrow microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of novel therapeutic approaches for multiple myeloma.
    Hideshima T; Anderson KC
    Nat Rev Cancer; 2002 Dec; 2(12):927-37. PubMed ID: 12459731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Intracellular Signaling Pathways in the Pathogenesis of Multiple Myeloma and Novel Therapeutic Approaches.
    Kizaki M; Tabayashi T
    J Clin Exp Hematop; 2016; 56(1):20-7. PubMed ID: 27334854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting multiple myeloma cells and their bone marrow microenvironment.
    Pagnucco G; Cardinale G; Gervasi F
    Ann N Y Acad Sci; 2004 Dec; 1028():390-9. PubMed ID: 15650264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma.
    Neri P; Bahlis NJ
    Curr Cancer Drug Targets; 2012 Sep; 12(7):776-96. PubMed ID: 22671924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
    Shay G; Hazlehurst L; Lynch CC
    J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment.
    Shay G; Tauro M; Loiodice F; Tortorella P; Sullivan DM; Hazlehurst LA; Lynch CC
    Oncotarget; 2017 Jun; 8(26):41827-41840. PubMed ID: 28611279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.
    Hideshima T; Mitsiades C; Tonon G; Richardson PG; Anderson KC
    Nat Rev Cancer; 2007 Aug; 7(8):585-98. PubMed ID: 17646864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights in Anti-Angiogenesis in Multiple Myeloma.
    Ribatti D; Vacca A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the bone marrow microenvironment in the pathogenesis of multiple myeloma].
    Jurczyszyn A; Gdula-Argasińska J; Kosmaczewska A; Skotnicki AB
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():521-33. PubMed ID: 25983291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma: the bone marrow microenvironment and its relation to treatment.
    Andrews SW; Kabrah S; May JE; Donaldson C; Morse HR
    Br J Biomed Sci; 2013; 70(3):110-20. PubMed ID: 24273897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biologically based therapies for myeloma.
    Anderson KC
    Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.
    Yasui H; Hideshima T; Richardson PG; Anderson KC
    Br J Haematol; 2006 Feb; 132(4):385-97. PubMed ID: 16412014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting SDF-1 in multiple myeloma tumor microenvironment.
    Bouyssou JM; Ghobrial IM; Roccaro AM
    Cancer Lett; 2016 Sep; 380(1):315-8. PubMed ID: 26655999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic strategies for multiple myeloma.
    Mimura N; Hideshima T; Anderson KC
    Exp Hematol; 2015 Aug; 43(8):732-41. PubMed ID: 26118499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials.
    Bazzi M; Badros A
    Cancer Biol Ther; 2010 Nov; 10(9):830-8. PubMed ID: 21045554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of antiangiogenic effect in multiple myeloma treatment.
    Barchnicka A; Olejniczak-Nowakowska M; Krupa-Kotara K; Grosicki S
    Adv Clin Exp Med; 2018 Feb; 27(2):291-297. PubMed ID: 29521075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biologically based therapeutic strategies in myeloma.
    Gupta D; Hideshima T; Anderson KC
    Rev Clin Exp Hematol; 2002 Sep; 6(3):301-24. PubMed ID: 12616700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, pathogenesis, and novel treatments for multiple myeloma.
    San Miguel J
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S1-4. PubMed ID: 19791422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.